Filtered By:
Management: Marketing

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 564 results found since Jan 2013.

New Breast Cancer Drug but at What Cost
The FDA approved Kadcyla for late stage breast cancer treatment. This is a good thing. Its about time.  And it will save many women's lives.But I have a real problem with the financials behind it. A month's treatment costs $9800 or $117,600 annually, which apparently is about twice the costs of Herceptin. These costs will mostly be covered by insurance - and we wonder why insurance premiums are going up.Immunogen, who developed it, expects to receive a $10.5 million pay off plus royalties of 3-5% of the expected world wide sales of $2 billion (with a b). To my tiny math brain, that means they get $60,000,000 (that's 6...
Source: Caroline's Breast Cancer Blog - February 23, 2013 Category: Cancer Tags: insurance costs medical news cynicism breast cancer treatment medication costs Source Type: blogs

Cancer is Not a Death Sentence
Life is Good! If you or a loved one has just gotten a cancer diagnosis, I want to reach out to you with this article to let you know you don’t have to be afraid. Of course you will be in the beginning. We are conditioned to fear cancer. But, I want you to know that you have enormous hope for a high quality, healthy, even long, life in your future if you want that and are willing to listen to the message from your body and take action to heal it. Let’s Face the Fear Factor First I realize that having “death” in the title is a little scary, but it’s true: Cancer is not your death sentence. Being born is. At birth...
Source: Life Learning Today - May 21, 2015 Category: Consumer Health News Authors: AgentSully Tags: Green Living Happy Healthy Living How To Solving Problems Spiritual alternative cancer cures alternative cancer healing Believe faith fear fear of cancer heal yourself healing cancer healing power love yourself Source Type: blogs

Ewing Sarcoma and a Purpose Driven Life: Part II
This is the final installment of a three-part short story which spans my 11th and 12th anniversaries of surviving bone cancer. You can read the first two parts here (in order): The Journey of Ewing Sarcoma Ewing Sarcoma and a Purpose Driven Life: Part I Ewing would need an assistant to help him fulfill his purpose. He considered contacting local high schools for cheap labor, but who was he kidding—nobody was as brilliant or fun as Pong. Some of their oxy and sewage-charged evenings were epic. If he returned his brain to that precise chemical imbalance then maybe he would remember the forest trails that led back to Pon...
Source: I've Still Got Both My Nuts: A True Cancer Blog - September 14, 2013 Category: Cancer Tags: life lessons cancer-free anniversary imaginative animals Source Type: blogs

Six Reasons Why Cancer is an Emotional Diagnosis Too
By Cynthia Hayes, Author, The Big Ordeal: Understanding and Managing the Psychological Turmoil of Cancer No matter when you hear the words, “You’ve got cancer,” you are bound to have an emotional reaction. The news is devastating, and the physical challenges that lie ahead are very real. But, unfortunately, that is only half the story. Cancer is an emotional diagnosis too, and our psychological and physical responses to the disease and its treatment are intertwined, coloring the entire experience. Why is cancer so emotional? We fear we will die For millennia, cancer has been a death sentence. So even though ...
Source: PickTheBrain | Motivation and Self Improvement - February 22, 2021 Category: Consumer Health News Authors: Cynthia Hayes Tags: featured health and fitness philosophy psychology self-improvement cancer healing illness pickthebrain self improvement Source Type: blogs

Pink Marketing should be Celebrated
 Is Pink Marketing making you feel pinked out, pinked off and pinked all over? Every October for the past several years, pink has been celebrated.  It started with pink ribbons and quickly turned to pink coffee pots, pink can openers and even pink screw drivers. Almost everything else that can be marketed is showing up in pink. Now anti-pink organizations have risen up with pink sleuths trying to out companies that are using Pink Marketing for self gain.  The concept is brilliant; pink stuff for breast cancer awareness. The whole month highlights the need for breast cancer screening and provides tributes to those who h...
Source: Life with Breast Cancer - October 17, 2013 Category: Cancer Authors: Kathy-Ellen Kups, RN Tags: Breast Cancer breast cancer awareness Pink Marketing Pink stuff Source Type: blogs

The Dangers of Big Corporate Health Care: Deceptive Marketing of Cancer Treatments
A series of articles over the last few months, culminating in an investigative report by Reuters, provided the newest example of what can go wrong when corporations provide direct care to vulnerable patients.  In this case, the vulnerable patients had cancer, and the corporation that provided them care was the Cancer Treatment Centers of America (CTCA).  I will try to go through the case chronologically.As Rueters reported, CTCA "was founded in 1988 by Richard J. Stephenson, who has been chairman ever since."The Founder's Checkered PastA Misdemeanor As Reuters noted,A graduate of Northwestern University Law Schoo...
Source: Health Care Renewal - March 11, 2013 Category: Health Medicine and Bioethics Commentators Tags: deception crime marketing Cancer Treatment Centers of America hospital systems complementary/ alternative medicine Source Type: blogs

C R Bard Settles Allegations of Kickbacks to Promote Radiation Treatment for Prostate Cancer
Screening for and aggressive treatment of prostate cancer has become an enormously lucrative business, if not necessarily a life-saving medical strategy.  The minimal media coverage of a recent settlement suggests that at least to some degree, it has been fueled by some questionable practices.The CR Bard SettlementAs reported by the Atlanta Journal Constitution,A medical device company on Monday agreed to pay a $48.2 million settlement to resolve claims by a Georgia employee that it paid kickbacks to doctors and customers who bought radiation treatment for prostate cancer.C.R. Bard Inc., which is headquartered in New ...
Source: Health Care Renewal - May 16, 2013 Category: Health Medicine and Bioethics Commentators Tags: kickbacks impunity C R Bard prostate cancer whistle-blowers legal settlements deferred prosecution agreement Source Type: blogs

About that Cancer Moonshot
By KIM BELLARD Joe Biden hates cancer.  He led the Cancer Moonshot in the Obama Administration, and, as President, he reignited it, vowing to cut death rates in half over the next 25 years.  Last month, on the 60th anniversary of President Kennedy’s historic call for an actual moonshot, he vowed “to end cancer as we know it. And even cure cancers once and for all.” But, as several recent studies show, cancer is still surprising us.  ————— Our body has its own defenses against cancer, such as T-cells, and great strides have been made in cancer therapies, includi...
Source: The Health Care Blog - October 6, 2022 Category: Consumer Health News Authors: matthew holt Tags: Health Policy Public Health Biden Cancer Cancer Moonshot Source Type: blogs

Breast Cancer Awareness Ads and Campaigns – Does the End Justify the Means?
There seems to be no end to what many would call provocative, and some would call tasteless, ads and campaigns that continue to pop up under the guise of supporting breast cancer awareness. Sometimes it seems they must be trying to outdo one another. Sex sells; it even sells breast cancer awareness. Proponents of such ads and campaigns argue that grabbing the attention first is what matters. Meaningful conversation can start later. So, does this kind of logic work for you? Is any kind of awareness better than no awareness at all? Does the end justify the means? I say no; it does not. Trivializing a deadly disease is wrong....
Source: Disruptive Women in Health Care - October 31, 2013 Category: Health Medicine and Bioethics Commentators Authors: dw at disruptivewomen.net Tags: Access Cancer Cost Source Type: blogs

The mammogram benefit discussion
There have been a few (thousand) discussions on the benefits of regular mammograms in the past few years. There are all sorts of claims on the problems of false positives, over diagnosis, false negatives, and all that. So stop the presses and read the results of this latest survey. Its a bit of a statistics lesson so allow me to break it down with my stellar liberal arts education and marketing backgroundThis survey looked at the incidence of breast cancer and the increased diagnosis trend from 1941 on. The first half of the time studied was from 1941 to the 1970s before mammograms - the base data.* Then it looked at the r...
Source: Caroline's Breast Cancer Blog - July 16, 2014 Category: Cancer Tags: breast cancer cancer diagnosis mammogram Source Type: blogs

A Physician Looks on the "Bright Side" of Metastatic Breast Cancer Survival and a Patient Advocate Looks On the Other Side
According to Forbes contributor Elaine Schattner, a physician who is writing a book on public perception of cancer, there is a "bright side" to metastatic breast cancer survival rates.Dr. Schatter cites a paper by Dr. Patricia Steeg of the National Cancer Institute (NCI) that calls out an “alarming” but debatable decline in survival in other advanced cancers and a general lack of progress against metastatic disease. But Dr. Schatter focuses (here) on the "bright side" by offering as evidence these graphs of median survival (left) and 5-year relative survival (right) after an initial diagnosis of met...
Source: Pharma Marketing Blog - May 15, 2016 Category: Pharmaceuticals Tags: breast cancer metastatic breast cancer Source Type: blogs

A Physician Looks on the " Bright Side " of Metastatic Breast Cancer Survival and a Patient Advocate Looks On the Other Side
According to Forbes contributor Elaine Schattner, a physician who is writing a book on public perception of cancer, there is a & quot;bright side & quot; to metastatic breast cancer survival rates. Dr. Schatter cites a paper by Dr. Patricia Steeg of the National Cancer Institute (NCI) that calls out an “alarming” but debatable decline in survival in other advanced cancers and a general lack of progress against metastatic disease. But Dr. Schatter focuses ( here ) on the & quot;bright side & quot; by offering as evidence these graphs of median survival (left) and 5-year relative survival (right) after an initial diagno...
Source: Pharma Marketing Blog - May 15, 2016 Category: Pharmaceuticals Tags: breast cancer metastatic breast cancer Source Type: blogs

Will Cancer Drugs Ever Be As Affordable As Retrovirals in Developing Countries?
By ASHLEY ANDREOU In 2014, the majority of international health aid was dedicated to HIV. So, one might reasonably assume that this is the largest health problem facing the world. Yet, HIV only constitutes 4% of the global burden of disease. In 2014, noncommunicable diseases (NCDs) made up 50% of the entire disease burden, but only received 2% of all global health funds. The disease burden of NCDs is fast outpacing that of infectious diseases. Despite this, the proportion of global health financing dedicated to combatting NCDs has remained constant over the past 15 years at 1 to 2%. Currently, 32.6 million individuals are...
Source: The Health Care Blog - May 17, 2018 Category: Consumer Health News Authors: Matthew Holt Tags: OP-ED Biologic generics Cancer Pharmaceuitcals Retrovirals Source Type: blogs

Will Cancer Drugs Ever Be As Affordable As Retrovirals in Low and Middle Income Countries?
By ASHLEY ANDREOU In 2014, the majority of international health aid was dedicated to HIV. So, one might reasonably assume that this is the largest health problem facing the world. Yet, HIV only constitutes 4% of the global burden of disease. In 2014, noncommunicable diseases (NCDs) made up 50% of the entire disease burden, but only received 2% of all global health funds. The disease burden of NCDs is fast outpacing that of infectious diseases. Despite this, the proportion of global health financing dedicated to combatting NCDs has remained constant over the past 15 years at 1 to 2%. Currently, 32.6 million individuals are...
Source: The Health Care Blog - May 17, 2018 Category: Consumer Health News Authors: Matthew Holt Tags: OP-ED Biologic generics Cancer Pharmaceuitcals Retrovirals Source Type: blogs